NATCOPHARM.NS vs. IAU
NATCOPHARM.NS (Natco Pharma Limited) is a stock, while IAU (iShares Gold Trust) is Gold fund tracking the LBMA Gold Price. Over the past 10 years, NATCOPHARM.NS returned 6.58%/yr vs 17.50%/yr for IAU. At a correlation of -0.04, they often move in opposite directions.
Performance
NATCOPHARM.NS vs. IAU - Performance Comparison
Loading charts...
Different Trading Currencies
NATCOPHARM.NS is traded in INR, while IAU is traded in USD. To make them comparable, the IAU values have been converted to INR using the latest available exchange rates.
Returns By Period
In the year-to-date period, NATCOPHARM.NS achieves a 1.91% return, which is significantly lower than IAU's 10.70% return. Over the past 10 years, NATCOPHARM.NS has underperformed IAU with an annualized return of 6.58%, while IAU has yielded a comparatively higher 17.50% annualized return.
NATCOPHARM.NS
- 1D
- -1.69%
- 1M
- -18.34%
- YTD
- 1.91%
- 6M
- -3.05%
- 1Y
- 7.58%
- 3Y*
- 14.17%
- 5Y*
- -1.76%
- 10Y*
- 6.58%
IAU
- 1D
- 0.91%
- 1M
- -1.03%
- YTD
- 10.70%
- 6M
- 13.40%
- 1Y
- 47.82%
- 3Y*
- 38.10%
- 5Y*
- 25.13%
- 10Y*
- 17.50%
NATCOPHARM.NS vs. IAU - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
NATCOPHARM.NS Natco Pharma Limited | 1.91% | -34.53% | 71.72% | 46.21% | -37.35% | -5.57% | 63.99% | -11.63% | -28.51% | 67.49% |
IAU iShares Gold Trust | 10.70% | 71.79% | 30.69% | 13.62% | 10.05% | -2.09% | 28.18% | 20.97% | 7.14% | 5.89% |
Correlation
The correlation between NATCOPHARM.NS and IAU is 0.05, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.05 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.03 |
Correlation (5Y) Calculated over the trailing 5-year period | -0.00 |
Correlation (10Y) Calculated over the trailing 10-year period | -0.01 |
Correlation (All Time) Calculated using the full available price history since Jul 4, 2007 | -0.04 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
NATCOPHARM.NS vs. IAU — Risk / Return Rank
NATCOPHARM.NS
IAU
NATCOPHARM.NS vs. IAU - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Natco Pharma Limited (NATCOPHARM.NS) and iShares Gold Trust (IAU). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| NATCOPHARM.NS | IAU | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.64 | ||
| Sortino ratioReturn per unit of downside risk | -1.68 | ||
| Omega ratioGain probability vs. loss probability | 1.07 | 1.35 | -0.28 |
| Calmar ratioReturn relative to maximum drawdown | 0.32 | 2.79 | -2.47 |
| Martin ratioReturn relative to average drawdown | 0.57 | 7.11 | -6.54 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| NATCOPHARM.NS | IAU | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.20 | 1.84 | -1.64 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.05 | 1.44 | -1.49 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.20 | 1.11 | -0.91 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.28 | 0.86 | -0.58 |
Drawdowns
NATCOPHARM.NS vs. IAU - Drawdown Comparison
The maximum NATCOPHARM.NS drawdown since its inception was -89.98%, which is greater than IAU's maximum drawdown of -29.82%. Use the drawdown chart below to compare losses from any high point for NATCOPHARM.NS and IAU.
Loading charts...
Drawdown Indicators
| NATCOPHARM.NS | IAU | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -89.98% | -29.82% | -60.16% |
Max Drawdown (1Y)Largest decline over 1 year | -23.82% | -17.24% | -6.58% |
Max Drawdown (3Y)Largest decline over 3 years | -53.00% | -17.24% | -35.76% |
Max Drawdown (5Y)Largest decline over 5 years | -54.29% | -17.24% | -37.05% |
Max Drawdown (10Y)Largest decline over 10 years | -55.44% | -20.18% | -35.26% |
Current DrawdownCurrent decline from peak | -41.82% | -13.38% | -28.44% |
Average DrawdownAverage peak-to-trough decline | -35.81% | -9.45% | -26.36% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 13.36% | 6.75% | +6.61% |
Volatility
NATCOPHARM.NS vs. IAU - Volatility Comparison
Natco Pharma Limited (NATCOPHARM.NS) has a higher volatility of 18.16% compared to iShares Gold Trust (IAU) at 5.18%. This indicates that NATCOPHARM.NS's price experiences larger fluctuations and is considered to be riskier than IAU based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| NATCOPHARM.NS | IAU | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 18.16% | 5.18% | +12.98% |
Volatility (6M)Calculated over the trailing 6-month period | 29.61% | 22.81% | +6.80% |
Volatility (1Y)Calculated over the trailing 1-year period | 38.00% | 26.19% | +11.81% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 34.09% | 17.54% | +16.55% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 34.21% | 15.86% | +18.35% |
Dividends
NATCOPHARM.NS vs. IAU - Dividend Comparison
NATCOPHARM.NS's dividend yield for the trailing twelve months is around 0.54%, while IAU has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
IAU iShares Gold Trust | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
NATCOPHARM.NS Natco Pharma Limited | 0.54% | 0.55% | 0.41% | 1.17% | 1.11% | 0.39% | 0.91% | 1.18% | 1.25% | 0.75% | 0.35% | 0.17% |
Frequently Asked Questions
NATCOPHARM.NS and IAU have a correlation of 0.05, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
Find the right allocation for NATCOPHARM.NS and IAU
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer